Jamaat-e-Islami Bangladesh: From Ban to Ban

To ban or not to ban?

The past four years have seen a steady increase in the number of companies that offer direct-to-consumer (DTC) genetic testing services and in the number of such tests for genetic risk factors, including a wide range of diseases and other non-disease-related traits. These companies sell their tests outside the traditional healthcare setting and often do not involve healthcare professionals for ...

Rimonabant: From RIO to Ban

Endocannabinoid antagonism as a treatment for obesity and the metabolic syndrome became a hugely anticipated area of pharmacology at the start of the century. The CB1 receptor antagonist Rimonabant entered the European mass market on the back of several trials showing weight loss benefits alongside improvements in numerous other elements of the metabolic syndrome. However, the drug was quickly ...

To ban or not to ban? - that is the question.

Vending machines in schools: to ban or not to ban?

hydrolysate, soy and conventional cow milk formulas on incidence of atopic disease in high risk infants. Annals of Allergy 1989; 63: 102–6. 4 Chandra R. Five-year follow-up of high risk infants with family history of allergy who were exclusively breastfed or fed partial whey hydrolysate, soy and conventional cow’s milk formulas. Journal of Pediatriatric Gastroenterology and Nutrition 1997; 24: ...

From BAN to AmI-BAN: micro and nano technologies in future Body Area Networks

At the University of Twente we have been researching mobile healthcare applications since 1999. Since 2002 the University of Twente and partners have been developing health Body Area Networks (BANs) and a BAN service platform. We define a BAN as a network of communicating devices worn on, around or in the body which provides mobile services to the user. The BAN may also communicate to remote us...